fda warning bpc 157 not approved safety concerns panel backs compounded BPC-157, KPV peptides in win for RFK Jr Stuffy nose? Reach for phenylephrine!
Stuffy nose? Reach for phenylephrine! Well, not anymore. Last week, the FDA announced it is proposing to remove oral phenylephrine as an active ingredient that can be used in OTC drug products WATCH: FDA advisory panel narrowly backs use of several peptides favored by RFK Jr. FDA Votes in Favor of Peptides After Lengthy Deliberation Drug Topics FDA to review 7 popular peptides touted for weight loss, healing and longevity
Pay in 4 interest-free payments of $6.11 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8


